These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35242477)

  • 41. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2016 Jan; (1):CD009530. PubMed ID: 26797965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant
    Okoliegbe IN; Hijazi K; Cooper K; Ironside C; Gould IM
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816722
    [No Abstract]   [Full Text] [Related]  

  • 43. Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis.
    De Baets F; Schelstraete P; Haerynck F; Van Biervliet S; De Bruyne R; Franckx H; Van Daele S
    Pediatr Pulmonol; 2014 Apr; 49(4):414-6. PubMed ID: 24039244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.
    Lambiase A; Catania MR; Del Pezzo M; Rossano F; Terlizzi V; Sepe A; Raia V
    Eur J Clin Microbiol Infect Dis; 2011 Aug; 30(8):973-80. PubMed ID: 21279730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment.
    Ridderberg W; Bendstrup KE; Olesen HV; Jensen-Fangel S; Nørskov-Lauritsen N
    J Cyst Fibros; 2011 Dec; 10(6):466-9. PubMed ID: 21835703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin.
    Filipic B; Malesevic M; Vasiljevic Z; Lukic J; Novovic K; Kojic M; Jovcic B
    Front Cell Infect Microbiol; 2017; 7():224. PubMed ID: 28611955
    [No Abstract]   [Full Text] [Related]  

  • 47. Motility, Biofilm Formation and Antimicrobial Efflux of Sessile and Planktonic Cells of
    Nielsen SM; Penstoft LN; Nørskov-Lauritsen N
    Pathogens; 2019 Jan; 8(1):. PubMed ID: 30691200
    [No Abstract]   [Full Text] [Related]  

  • 48. Emergence of Achromobacter xylosoxidans Bacteremia in a Tertiary Care Center: A Case Report and Literature Review.
    Dhakshna Murthi K; Naik S; Arumugam SL; J M; Kv L
    Cureus; 2024 Aug; 16(8):e68084. PubMed ID: 39347123
    [No Abstract]   [Full Text] [Related]  

  • 49. Transmission and Antibiotic Resistance of
    Gabrielaite M; Bartell JA; Nørskov-Lauritsen N; Pressler T; Nielsen FC; Johansen HK; Marvig RL
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33472899
    [No Abstract]   [Full Text] [Related]  

  • 50. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients.
    Wellinghausen N; Wirths B; Poppert S
    J Clin Microbiol; 2006 Sep; 44(9):3415-7. PubMed ID: 16954289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infection of a total hip prosthesis in a dog caused by Achromobacter(Alcaligenes) xylosoxidans.
    Girling SL; Innes JF
    J Small Anim Pract; 2006 Dec; 47(12):747-50. PubMed ID: 17201829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Achromobacter species endocarditis: A case report and literature review.
    Derber C; Elam K; Forbes BA; Bearman G
    Can J Infect Dis Med Microbiol; 2011; 22(3):e17-20. PubMed ID: 22942890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcaneal osteomyelitis due to Achromobacter xylosoxidans: a case report.
    Ozer K; Kankaya Y; Baris R; Bektas CI; Kocer U
    J Infect Chemother; 2012 Dec; 18(6):915-8. PubMed ID: 22286410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful Treatment of Aortic Endocarditis by
    La Bella G; Salvato F; Minafra GA; Bottalico IF; Rollo T; Barbera L; Tullio S; Corso G; Caputo SL; Nittis R; Arena F
    Antibiotics (Basel); 2022 Nov; 11(12):. PubMed ID: 36551343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bronchitis mimicking opportunistic lung infection in patients with human immunodeficiency virus infection/AIDS.
    Chechani V; Allam AA; Smith PR; Webber CA; Kamholz SL
    N Y State J Med; 1992 Jul; 92(7):297-300. PubMed ID: 1518586
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Marsac C; Berdah L; Thouvenin G; Sermet-Gaudelus I; Corvol H
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34084788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cellulitis due to Achromobacter xylosoxidans during bortezomib therapy for multiple myeloma].
    Kikuchi T; Mori T; Kohashi S; Yamane Y; Okayama M; Mashima E; Murakami K; Shimizu T; Kurihara Y; Ueda T; Suzuki T; Okamoto S
    Rinsho Ketsueki; 2016 Feb; 57(2):175-9. PubMed ID: 26935636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Achromobacter xylosoxidans Bacteremia in a Liver Transplant Patient: A Case Report and Literature Review.
    Barakat M; Sajid J
    Cureus; 2022 Jun; 14(6):e26048. PubMed ID: 35747118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Case of Pyometra Caused by Achromobacter xylosoxidans and γ-Streptococcus in an Elderly Frail Woman.
    Mukai S; Isono H; Kondo K; Ihara K; Isono M; Ogawa H
    Cureus; 2022 Nov; 14(11):e32016. PubMed ID: 36600853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.